We further observed analogous expression of IGF2BP2, an oncofetal protein and downstream target of HMGA2 in 100% of human LAM and TSC lesions [146], similar to the gene’s pattern of co-expression with HMGA2 in rhabdomyosarcoma and during myoblast proliferation [5,147]. Here, HMGA2 is linked to lymphangioleiomyomatosis.